Two-year assessment of entecavir resistance in Lamivudine-refractory hepatitis B virus patients reveals different clinical outcomes depending on the resistance substitutions present.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples